The Dementia Consortium is a charity-industry partnership between Alzheimer’s Research UK and world leading pharmaceutical companies that bring together a collective expertise in dementia to co-fund research projects of common interest.

With Industry Partner support, research projects funded by the Dementia Consortium aim to validate novel targets for the diseases that cause dementia and to progress the most promising targets to clinical studies. The ultimate aim of the Dementia Consortium is to bring benefit to patients through accelerated dementia drug discovery and the development of new treatments.